Go Pro
NASDAQ:EUDA

EUDA Health Q4 2025 Earnings Report

EUDA Health logo
$17.68 +0.27 (+1.52%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$17.45 -0.23 (-1.33%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EUDA Health EPS Results

Actual EPS
-$0.44
Consensus EPS
-$1.20
Beat/Miss
Beat by +$0.76
One Year Ago EPS
N/A

EUDA Health Revenue Results

Actual Revenue
$1.92 million
Expected Revenue
$3.90 million
Beat/Miss
Missed by -$1.98 million
YoY Revenue Growth
N/A

EUDA Health Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

EUDA Health Earnings Headlines

EUDA Health (NASDAQ:EUDA) Shares Down 0.4% - Should You Sell?
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks.tc pixel
EUDA Health Holdings Ltd. Wt
See More EUDA Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like EUDA Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on EUDA Health and other key companies, straight to your email.

About EUDA Health

EUDA Health (NASDAQ:EUDA) is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market. EUDA Health Holdings became a publicly traded company on the Nasdaq following a business combination with a special purpose acquisition company. Information about its current leadership and the full scope of its operating subsidiaries is limited.

View EUDA Health Profile